A randomized double-blind, placebo-controlled study of SEL-212 in patients with gout refractory to conventional therapy. SEL 212/301
Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome : A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant CORT125134-455 (GRACE)
Glucocorticoid Receptor Antagonism in the Treatment of Hypercorticolism in Patients with Cortisol Secreting Adrenal Adenomas or Hyperplasia (GRADIENT): A Phase 3 , Randomized. Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Relacorilant CORT125134-456
A Double-Blinded, Randomized, Placebo-Controlled, Phase 2B Trial of IMC-1 for the Treatment of Fibromyalgia PRID-202
A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects with Gout and Mild to Moderate CKD ALLN-346-202